Activated protein C restores hepatic microcirculation during sepsis by modulating vasoregulator expression

Shock

Volumn 36, Issue 4, 2011, Pages 361-369

  Keller, Steve A ^a   Moore, Cathy C ^a   Clemens, Mark G ^b   McKillop, Iain H ^a,b   Huynh, Toan ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Activated protein C; endothelin 1; intravital microscopy; nitric oxide; sepsis

Indexed keywords

ACTIVATED PROTEIN C; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MESSENGER RNA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FIBRINOLYSIS; GENE EXPRESSION; INFLAMMATION; LIGATION; LIVER CIRCULATION; LIVER FUNCTION; MALE; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PERFUSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN EXPRESSION; PUNCTURE; RAT; SEPSIS; SHAM PROCEDURE; SURVIVAL; VASOCONSTRICTION; VELOCITY;

ANIMALS; ENDOTHELIN-1; LIVER; MALE; MICROCIRCULATION; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SEPSIS;

EID: 80052962754     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31822c7380     Document Type: Article

References (37)

1. Hodgin KE, Moss M: The epidemiology of sepsis. Curr Pharm Des 14(19): 1833-1839, 2008.
2. Ince C: The microcirculation is the motor of sepsis. Crit Care 9(Suppl 4): S13-S19, 2005. (Pubitemid 41498527)
3. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138-150, 2003. (Pubitemid 36056721)
4. Esmon CT: Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 32(Suppl):149-160, 2006.
5. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thrombosis and haemostasis 76(5):738-742, 1996. (Pubitemid 26388179)
6. Conkling PR, Chua CC, Nadler P, Greenberg CS, Doty E, Misukonis MA, Haney AF, Bast RC, Jr., Weinberg JB: Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function. Cancer research 48(19):5604-5609, 1988.
7. Yang L, Manithody C, Rezaie AR: Activation of protein C by the thrombinthrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci USA 103(4):879-884, 2006. (Pubitemid 43212190)
8. Vollmar B, Menger MD: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89(4): 1269-1339, 2009.
9. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33(4):222-227, 1991.
10. Sonin NV, Garcia-Pagan JC, Nakanishi K, Zhang JX, Clemens MG: Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock 11(3):175-179, 1999.
11. Pannen BH, Kohler N, Hole B, Bauer M, Clemens MG, Geiger KK: Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest 102(6):1220-1228, 1998. (Pubitemid 28436282)
12. Lendemans S, Peszko A, Oberbeck R, Schmitz D, Husain B, Burkhard M, Schade FU, Flohe S: Microcirculatory alterations of hepatic and mesenteric microcirculation in endotoxin tolerance. Shock 29(2):223-231, 2008.
13. Toussaint S, Gerlach H: Activated protein C for sepsis. N Engl J Med 361(27): 2646-2652, 2009.
14. Huynh T, Nguyen N, Keller S, Moore C, Shin MC, McKillop IH: Reducing leukocyte trafficking preserves hepatic function after sepsis. J Trauma 69(2): 360-367, 2010.
15. Lehmann C, Scheibe R, Schade M, Meissner K, Grundling M, Usichenko T, Wendt M, Hung O, Whynot S, Murphy M, et al.: Effects of activated protein C on the mesenteric microcirculation and cytokine release during experimental endotoxemia. Can J Anaesth 55(3):155-162, 2008. (Pubitemid 351449432)
16. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 85(2):205-211, 1979. (Pubitemid 9097866)
17. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24 Suppl 152-157, 2005.
18. Bernard GR, Macias WL, Joyce DE, Williams MD, Bailey J, Vincent JL: Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Crit Care 7(2):155-163, 2003. (Pubitemid 36432674)
19. Baveja R, Zhang JX, Clemens MG: In vivo assessment of endothelin-induced heterogeneity of hepatic tissue perfusion. Shock 15(3):186-192, 2001. (Pubitemid 33599101)
20. Kamoun WS, Shin MC, Keller S, Karaa A, Huynh T, Clemens MG: Induction of biphasic changes in perfusion heterogeneity of rat liver after sequential stress in vivo. Shock 24(4):324-331, 2005. (Pubitemid 41416517)
21. Norris EJ, Culberson CR, Narasimhan S, Clemens MG: The liver as a central regulator of hydrogen sulfide. Shock, 2011.
22. Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH: Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 291(1):120-129, 2010.
23. Huynh T, Lemasters JJ, Bracey LW, Baker CC: Proinflammatory Kupffer cell alterations after femur fracture trauma and sepsis in rats. Shock 14(5): 555-560, 2000.
24. Keller SA, Paxian M, Ashburn JH, Clemens MG, Huynh T: Kupffer cell ablation improves hepatic microcirculation after trauma and sepsis. J Trauma 58(4):740-749; discussion 749-751, 2005.
25. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endotheliumderived relaxing factor. Proc Natl Acad Sci USA 85(24):9797-9800, 1988. (Pubitemid 19027212)
26. Hendrickson H, Chatterjee S, Cao S, Morales Ruiz M, Sessa WC, Shah V: Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver. Am J Physiol Gastrointest Liver Physiol 285(3):G652-G660, 2003. (Pubitemid 37021825)
27. Michel JB, Feron O, Sacks D, Michel T: Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 272(25): 15583-15586, 1997. (Pubitemid 27265522)
28. Nathan L, Leveno KJ: Group a streptococcal puerperal sepsis: historical review and 1990s resurgence. Infect Dis Obstet Gynecol 1(5):252-255, 1994.
29. Heemskerk S, Masereeuw R, Russel FG, Pickkers P: Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol 5(11): 629-640, 2009.
30. Tuchschmidt J, Fried J, Swinney R, Sharma OP: Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 17(8):719-723, 1989. (Pubitemid 19199497)
31. Pannen BH, Bauer M, Zhang JX, Robotham JL, Clemens MG: Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 270(1 Pt 2):H7-H15, 1996.
32. Yokoyama Y, Wawrzyniak A, Baveja R, Sonin N, Clemens MG, Zhang JX: Altered endothelin receptor expression in prehepatic portal hypertension predisposes the liver to microcirculatory dysfunction in rats. J Hepatol 35(1): 29-36, 2001. (Pubitemid 32646221)
33. Keller SA, Moore CC, Evans SL, McKillop IH, Huynh T: Activated protein C alters inflammation and protects renal function in sepsis. J Surg Res 2011.
34. van Rooij E: The art of microRNA research. Circ Res 108(2):219-234, 2011.
35. Risoe PK, Ryg U, Wang YY, Rutkovskiy A, Smedsrod B, Valen G, et al.: Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR-142-3p. Shock, 2011.
36. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al.: MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4(10):e7405, 2009.
37. Yeligar S, Tsukamoto H, Kalra VK: Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. J Immunol 183(8): 5232-5243, 2009.